The DES Center

Filter Your Results

 

News

 

Postmarket Registry Evaluates B. Braun's Coroflex Isar Sirolimus-Eluting Stent

June 26, 2017 -- Findings from postmarket surveillance of the Coroflex Isar drug-coated stent (B. Braun Melsungen AG) for the treatment of real-world patients with de novo and…

Five-Year Results Published From the COMPARE II Trial of Terumo's Nobori Biodegradable DES

June 26, 2017 -- The final 5-year report from the COMPARE II trial of an abluminal biodegradable polymer biolimus-A9 -- eluting stent (BP-BES) versus a durable polymer everoli…

Two-Year Results Published From the ISAR-ABSORB Registry of Everolimus-Eluting Bioresorbable Stents in Routine Practice

June 26, 2017 -- Two-year clinical outcomes from the ISAR-ABSORB registry of patients treated in routine practice with everolimus-eluting bioresorbable stent (BRS) implantatio…

Clinical Study of Medtronic's Resolute Onyx 2.0-mm DES for Extra Small Vessels Meets Primary Endpoint

May 18, 2017 -- Medtronic announced that the Resolute Onyx 2.0-mm drug-eluting stent (DES) met its primary endpoint of target lesion failure (TLF) at 1 year for the treat…

Biotronik's Magmaris Resorbable Scaffold Shows Reduced Risk of Thrombosis

May 17, 2017 -- Biotronik announced data demonstrating that the company's Magmaris resorbable scaffold offers a reduced risk of thrombus formation compared with a polymeri…

Micell's MiStent Achieves Primary Endpoint in All-Comers DESSOLVE III Trial

May 16, 2017 -- Micell Technologies, Inc. announced that positive 12-month data from its DESSOLVE III clinical trial were presented by Prof. Robbert J. de Winter, MD, dur…

Shockwave Medical's Coronary Lithoplasty System Receives CE Mark Approval

May 15, 2017 -- Shockwave Medical, Inc. announced European CE Mark approval for the company’s coronary Lithoplasty system for the treatment of calcified p…

Long-Term Safety and Efficacy of Bioresorbable Vascular Scaffolds Versus Metallic Stents Compared in Meta-Analysis

May 8, 2017 -- A meta-analysis of randomized trials evaluating the long-term safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds (BVS) versus everolimus…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.